Citigroup’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
Citigroup's CLBT Position: Q3 2026 in Review
Citigroup increased its Cellebrite (CLBT) stake by 819% in Q3 2026, buying an estimated $38.4M and bringing the position to 3,237,542 shares worth $36.5M. The position accounts for 0.01% of the portfolio, ranked #900.
Citigroup first reported a position in CLBT in Q4 2021 and has held it in 20 quarters since. 57 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.
- Citigroup held 3,237,542 shares of Cellebrite worth $36.5M as of Q3 2026.
- Citigroup bought 2,885,192 Cellebrite shares in Q3 2026, an estimated $38.4M.
- Cellebrite made up 0.01% of Citigroup's portfolio in Q3 2026, its #900 holding.
- Citigroup first reported a position in Cellebrite in Q4 2021 and has held it in 20 quarters since.
- 57 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.